|
GLYC Glycomimetics Inc 1253689 |
| Balance Sheet |
|
Current Assets
|
11,091,454 |
|
Assets
|
11,091,454 |
|
Current Liabilities
|
5,777,892 |
|
Liabilities
|
5,777,892 |
|
Equity
|
5,313,562 |
|
Shares Out
|
64,484,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-31,098,078 |
|
Investing Cash Flow
|
20,028 |
| Market Analysis |
Market Cap
|
10,723,679 |
|
Price
|
0.28 |
|
BVPS
|
0.08 |
|
PB
|
3.40 |
|
EPS
|
-0.61 |
|
PS
|
868.74 |
|
FCF
|
-31,078,050 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/13 |
-0.59 |
|
0.50 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GLYC documents filed with the SEC.
GLYC Filings
Clear
